(1)
Polymeric Nanoparticle-Mediated Delivery of Oncolytic Measles Virus for Targeted Therapy in Cervical Cancer. Pharmaceutical Communications 2024, 3 (01). https://doi.org/10.55627/pharma.003.001.0887.